Despite strong evidence of effectiveness, colorectal cancer (CRC) screening remains
underused. Currently, there are several options for CRC screening, each with its own …

Mortality from colorectal cancer is reduced through screening and early detection; moreover,
removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk …

Background A next-generation multitarget stool DNA test, including assessments of DNA
molecular markers and hemoglobin level, was developed to improve the performance of …

There remains a need to synthesize linkages between social determinants of health (SDOH)
and cancer screening to reduce persistent inequities contributing to the US cancer burden …

Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the
second leading cause of cancer death. Arising through three major pathways, including …

Abstract In the United States, colorectal cancer (CRC) is the fourth most common cancer
diagnosed among adults and the second leading cause of death from cancer. For this …

Rising trends in the incidence and mortality of early-onset colorectal cancer (CRC) in those
who are younger than 50 years have been well established. These trends have spurred …

This document updates the colorectal cancer (CRC) screening recommendations of the US
Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American …

Colorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide.
However, colon cancer incidence and mortality is declining over the past decade owing to …

Importance Colorectal cancer is the second leading cause of cancer death in the United
States. In 2016, an estimated 134 000 persons will be diagnosed with the disease, and …